Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

NCT06630104 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Lymphoproliferative Disorder
Multiple Myeloma

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
OTHER: Electronic Health Record Review
PROCEDURE: Follow-Up
OTHER: Genetic Counseling
OTHER: Genetic Testing

Sponsor

Mayo Clinic